SCHB vs XBI
Schwab US Broad Market ETF vs SPDR S&P Biotech ETF
SCHB—
Schwab US Broad Market ETF
Total US equity market.
Expense: —Yield: —
XBI—
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: —Yield: —
Side-by-side metrics
| Metric | SCHB | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | Schwab | State Street |
SCHB top holdings
Holdings data unavailable for SCHB.
XBI top holdings
Holdings data unavailable for XBI.
About SCHB
SCHB (Schwab US Broad Market ETF) is Total US equity market.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index.